Article Text

Download PDFPDF
Long-term follow-up of quiescent choroidal neovascularisation associated with age-related macular degeneration or pachychoroid disease
  1. Raimondo Forte1,
  2. Florence Coscas1,2,
  3. Rita Serra2,3,
  4. Diogo Cabral2,4,
  5. Donato Colantuono1,
  6. Eric H Souied1
  1. 1Department of Ophthalmology, Centre Hospitalier Intercommunal de Creteil, University Paris Est Creteil XII, Creteil, France
  2. 2Centre ophtalmologique de l'Odéon, Saint Germain, Paris, France
  3. 3Department of Surgical Sciences, Eye Clinic, University of Cagliari, Cagliari, Italy
  4. 4NOVA Medical School, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisbon, Portugal
  1. Correspondence to Dr Raimondo Forte, Department of ophthalmology, Centre Hospitalier Intercommunal de Creteil, University Paris Est Creteil XII, Creteil, France; raiforte{at}gmail.com

Abstract

Aims To evaluate the long-term progression of quiescent type 1 choroidal neovascularisation (CNV) associated with age-related macular degeneration (AMD) or with pachychoroid disease.

Methods All cases of quiescent type 1 CNV with a minimum follow-up of 12 months seen at the Department of Ophthalmology of University Paris Est, Creteil and at the Centre Ophtalmologique de l’Odeon, Paris, between June 2009 and December 2018 were retrospectively reviewed. Optical coherence tomography angiography (OCT-A) of eyes not showing CNV activation during 24 months was evaluated for quantitative analyses of CNV status biomarkers (fractal dimension, lacunarity, vessel density, aspect ratio, CNV area).

Results A total of 67 eyes (65 patients, 43 females, mean age 76.63±9.7 years) with quiescent CNV and a mean follow-up of 49.56±27.3 (12–112) months were included. Of 28 eyes showing activation of quiescent CNV, 12 eyes with pachychoroid-associated CNV showed reduced visual loss (−3.28 ETDRS letters, p=0.7 vs −13.03 ETDRS letters, p=0.02), greater choroidal thinning (−59.5 µm, p=0.03 vs – 16.36 µm, p=0.3) and needed less antivascular endothelial growth factor intravitreal injections (IVI) (0.09 vs 0.21, p=0.01) than 16 eyes with AMD-associated CNV. CNV area was the only OCT-A biomarker to significantly change during 24 months in inactive quiescent CNV (+29.5%, p=0.01, in pachychoroid group and +27.1%, p=0.03, in the AMD group).

Conclusion In the long-term follow-up, inactive quiescent CNV showed an increase of CNV area without significant changes of the other OCT-A biomarkers. Quiescent type 1 CNV undergoing activation showed greater response to IVI when associated to pachychoroid.

  • optical coherence tomography angiography
  • quiescent
  • pachychoroid
  • choroid
  • CNV
  • AMD
View Full Text

Statistics from Altmetric.com

Footnotes

  • Contributors RF: research design, data acquisition, data analysis, manuscript preparation. FC: data acquisition, data analysis, research design, manuscript preparation. RS: data acquisition, data analysis. DC: data acquisition, data analysis. DC: data acquisition, data analysis. EHS: research design, manuscript preparation.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data availability statement All data relevant to the study are included in the article or uploaded as supplementary information.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.